Peter Dabrock

Matthias Braun

Jens Ried

"Individualized medicine" is a catchphrase currently used to denote efforts in medical research and practice to establish tailored healthcare. The vision of "personalized" medicine has proved to be highly ambivalent, reflecting hype and hope - compared to the great expectations only very few applications have been realized up to now. The contributions to this volume discuss the challenges for patients, doctors, and the healthcare system and examine ethical and societal issues arising from one the most promising and most controversial developments in medical science and biotechnology. (Series: Medizin und Gesellschaft - Vol. 19)

Exploring Ethical and Societal Challenges for Healthcare

Individualized Medicine Between Hype and Hope

Hannah Schickl

Genome Editing Techniques are seen to be at the frontier of current research in the field of emerging biotechnologies. The latest revolutionary development, the so-called CRISPR technology, represents a paradigmatic example of the ambiguity of such techniques and has resulted in an international interdisciplinary debate on whether or not it is necessary to ban the application of this technique by means of a moratorium on its use for human germline modifications, particularly in human embryos in the reproduction process. However, given that other germline engineering techniques like mitochondrial (mt) DNA transfer techniques are already permitted and applied, the question arises what lies at the root of the apparent social unease about the modification of the human germline by Genome Editing Techniques like CRISPR. Against this background, the book seeks to make a substantial contribution to the current debate about a responsible and participatory framework for research on emerging biotechnologies by analysing underlying perceptions, attitudes, arguments and the reasoning on Genome Editing Techniques.

Peter Dabrock

About

Books

Join the club